Dr. Hans A. Nieper of Germany has this to say about B–17:

"In 1848, a substance was presented at the Society for Medicine in Moscow, which apparently had an obvious effect on some forms of cancer.  While I was in Freiburg in 1951 for my state examination as a physician, I had to evaluate a patient with a stomach cancer.  One of the chief physicians in the group of medical examiners present recommended that this substance be tested on the patient.  It was a bitter almond substance, one of the so-called beta-cyanogenic glucosides.  There are a good 50 of them in nature, the best known being amygdalin, Vitamin B–17, prunasin, cassavin and ficin. Unfortunately, in the United States, the greatest and most depressing tragic comedy of modern medicine developed around these substances.  It would be inappropriate to go into the history of the so-called laetrile affair in the United States, although I am, of course, quite familiar with the details.  As an explosive internal issue, the laetrile affair has almost attained the order of magnitude of the Vietnam conflict.  I still do not see how some of the exponents of official American cancer medicine, and certain bureaucracies in Washington, are going to emerge from this affair with clean hands.  The effect of this bitter almond substance is not strong, and can be observed only if the defense mechanisms are in operation.  In any event, it can and was clearly proven both clinically and experimentally, with positive results, at both the famous Sloan-Kettering Institute in New York, and at the Pasteur Institute in Paris.  An enormous suppression story was leaked to the press by a member of the New York institute.  A rather mysterious "testing" in five clinics, including the famous Mayo Clinic, led to the strong suspicion that certain oral (not intravenous) doses of laetrile were tested after having been previously and intentionally "contaminated" at the National Cancer Institute in Washington, with a certain highly poisonous cyano urea combination.  Officially, a "purification" was admitted.

The " dot on the i " to the whole affair was supplied by the clever Japanese.  Within the organism, the bitter almond substance ( Vitamin B–17, amygdalin, laetrile ) decomposes into cyanide, which is immediately detoxified, and (then) into benzaldehyde.

From an entirely different perspective, the Japanese found that benzaldehyde had a very positive effect against cancer cells, which additionally is very interesting from the point of view of its biochemical mechanism.  The Japanese supplied ample basic information, and both the experimental and clinical results were quite remarkable.  In 1980, an official journal of the National Cancer Institute of the United States reported, nicely wrapped up, on the excellent results obtained in Japan with benzaldehyde.  The fact that this is the active principle in the infamous "laetrile" was presumably only noticed later.  Once again, orthodoxy does have its element of stupidity.

The Point of this entire affair is not whether the preparation is particularly effective or not.  It is a matter of scientific and moral integrity.  Today benzaldehyde and mandelonitriles are important tools in the hands of tumor specialists, even though they do not perform miracles.  Orthodox medicine, of course, has no such offerings.

Incidentally, during the degradation of the bitter almond substance by the organism, a second substance with a cancer inhibiting effect is formed, thiocyanate.  Both chemically and in its action, it is related to allicin (from garlic) and allyl-isothiocyanate (from horseradish).  Perhaps it is due to the relatively low cancer inhibiting Protective action of these substances that orthodox medicine does not offer them.

To complete the Picture, a technical paper originating at Columbia University in New York was published, reporting that the cyanide released by the bitter almond substance was transformed inside the cancerous cell into a metabolite that is specifically cancer inhibiting.  The normal cell cannot accomplish this particular transformation.  The attempt to use the deviant ionic balance of the cancer cell as a starting point for cancer therapy has been quite successful, and in a direction other than that of sodium elimination from the cancer cell through the already mentioned taurine.  The cancer cell contains far more hydrogen ions than a normal cell.  Therefore, its pH value is lower than that of normal cells.  If one succeeded in removing the excessive hydrogen ions and thus raising the pH value, this might stop many of the metabolic processes sustaining the malignancy of the cancer cell.  It would be like removing the sparkplugs from the cancer cells.  In fact, the long and highly respected American physicist and chemist, Keith Brewer, succeeded in translating this concept into a realistic treatment program.

The cancer cell takes in rubidium and especially cesium, both elements that, because of the special characteristics of their electron shells, absorb free hydrogen ions.  Cesium is particularly effective.

For the rest of the organism, cesium is very harmless in the doses used in treatment, even following prolonged application.

Animal experiments and clinical results with this treatment, which only became known in the United States during the second half of 1981, are, in fact, remarkably good.  Because of the nontoxic nature of the method, its effects on cancerous tumors in man are obviously better and more interesting than the effects of well-known toxic chemotherapy measures.  Care must be taken, however, with this therapy of hydrogen ion neutralization in the tumor cell, to insure that the organism's immune and detoxification systems are in full operation as much as possible.  In any event, this therapy is appropriate even when the tumors already have considerable volume.  Results in Germany confirm those obtained in the United States.

Of course cesium therapy requires daily supplementation with potassium, and it belongs in the hands of well-trained specialists — as is often stressed in the USA.

The physicist and chemist Keith Brewer was a determining factor in implementing the isotope separation required for the manufacture of the American atomic bomb during World War II. It is understandable that this great accomplishment in the battle against cancer is psychologically very satisfying to him.  It should not be necessary to mention that this important development is not an orthodox medicine offering either.  Quite the contrary, the famous physicist Brewer is snubbed by the orthodox American cancer establishment despite of his great accomplishments.

Even urea in the amount of 7–15 grams daily has obviously spectacular effects on certain forms of cancer — especially advanced cancer of the liver.  Although in 1974 Dr. Danopuolos, Professor at the Greek Cancer Clinic discussed this in detail in the British magazine "Lancet" this path was not further pursued by orthodox medicine.  This therapy is very inexpensive, mostly harmless and can be administered for a prolonged period.  The underlying principle seems to be an antiviral effect.  The effect of the urea therapy is limited to cancers, which are known to be started by the foregoing viral infections.  This is true for liver cancers (hepatitis B) and for oral tumors (herpes virus).

A further method to detoxify the cancer cells from the inside consists of the introduction of L-glutathione, a compound with sulfureous amino acids.  Known results up to now permit prediction of benefits from this treatment.

The insights gained, which encompass the already mentioned cancer retarding or cancer-preventing "supervisory" steroid, DHEA, are new and fascinating for expert and layman alike.  About 60% of all people have enough of this substance in their blood to be sufficiently protected from the occurrence of cancer in their organism; although, as previously mentioned, some other factors, e.g., the blood type, complement levels and lymph-cell-bound tumosterone activity are additional contributors to the outcome. In the meantime, it has become possible to determine the level of DHEA in the bloodstream.  If it is too low, it can be increased.  The American company Searle produces DHEA synthetically.  More elegant, possibly, is a method to turn on the DHEA production of the body itself.  Apparently, this can be accomplished with a delay time of several weeks, by the already mentioned squalene.  When the DHEA level in the (blood) serum rises to a value of more than 3.3 mg/L, even threatening cancer tumors go into remission, of course, only under the assumption that the complex chain of further defense mechanisms is still functional or is repaired.  The DHEA has, to be precise, only a retarding effect on the metabolism of the cancer cell and the extracellular "little bodies" mentioned.  Further work is up to the body's own elimination system.

Certain observations suggest that the DHEA-Sulfate, which circulates with the blood, must first be de-sulfateded by a special factor so that it can become effective against cancer cells.  This de-sulfateded factor originates possibly from the pineal gland, a brain appendix, and/or from the thymus gland.

About 40% of the people probably have absolutely or relatively too little DHEA in their blood.  A little less than half of these develop a latent cancer which, however, during their lifetime will not reach the importance of a manifest illness. About 22% of all people die from a manifest cancerous illness.  The deficiency of DHEA, and an increased deficiency due to the onset of cancer, are correlated with interesting peculiarities of the personality.  Such people are, as a rule, not very aggressive, yes, decidedly "dear."  They are mostly somewhat depressed, or at least somewhat inactive.  And above all, they frequently suffer from "weak decision making ability", especially in the realm of business.

The extreme opposite of weak decision making ability is not decision making strength, as would seem to be the case.  It is recklessness.

I wish to present still one more comment.  In my total experience of observing several thousand-cancer patients, only two cases became known to me, which manifested criminal potential.  On the other hand, no doubt, recklessness goes hand in hand with criminal activity.  Will it some day be possible to eliminate the criminal potential in afflicted persons by the manipulation of steroids (like DHEA) within them?

This would be only too good, and it would fit so perfectly into the new and hopeful Tachyon Age.

I am quite confident that it is possible to bring this disease under control, something that to date, unfortunately, has not been the case.  It is important to start protective therapy immediately after a tumor operation, for an indefinite period of time, even if at first no further tumor is evident.  This protective therapy should be based partially on the aforementioned considerations.  Naturally orthodox medicine as a rule does not offer such proposals and, to the contrary, frequently misinforms patients when these questions arise." ...

... "The clinic for tumor research in Essen, Germany, considered quite orthodox, implies that continued chemotherapy, because of its toxic effect, can damage the body's own immune surveillance system.  "Therapeutic measures such as chemotherapy and irradiation impair certain cellular functions that are decisive for defense against tumors. This fact should be considered in the therapy concept." ...

© M.I.T. Management Interessengemeinschaft für Tachyonen-Feld-Energie GmbH

Friedrich-Rüder-Straße 1, 2900 Oldenburg, Federal Republic of Germany
First German printing — February 1981
English — May 1985